MicroRNAs in Metabolic Disease

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2013 Jan 18

PMID 23325474

Citations 131

Authors

Carlos Fernandez-Hernando

Cristina M Ramirez

Leigh Goedeke

Yajaira Suarez

Affiliations

Soon will be listed here.

Abstract

Alterations in the metabolic control of lipid and glucose homeostasis predispose an individual to develop cardiometabolic diseases, such as type 2-diabetes mellitus and atherosclerosis. Work over the last years has suggested that microRNAs (miRNAs) play an important role in regulating these physiological processes. The contribution of miRNAs in regulating metabolism is exemplified by miR-33, an intronic miRNA encoded in the Srebp genes. miR-33 controls cellular cholesterol export and fatty acid degradation, whereas its host genes stimulate cholesterol and fatty acid synthesis. Other miRNAs, such as miR-122, also play a critical role in regulating lipid homeostasis by controlling cholesterol synthesis and lipoprotein secretion in the liver. This review article summarizes the recent findings in the field, highlighting the contribution of miRNAs in regulating lipid and glucose metabolism. We will also discuss how the modulation of specific miRNAs may be a promising strategy to treat metabolic diseases.

Citing Articles

Regulatory Roles and Therapeutic Potential of miR-122-5p in Hypoxic-Ischemic Brain Injury: Comprehensive Review.

Bamahel A, Sun X, Wu W, Mu C, Liu J, Bi S Cell Biochem Biophys. 2025; .

PMID: 40016565 DOI: 10.1007/s12013-025-01686-6.

Epigenetic Modifications Associated With Wildland-Urban Interface (WUI) Firefighting.

Goodrich J, Furlong M, Urwin D, Gabriel J, Hughes J, Jung A Environ Mol Mutagen. 2025; 66(1-2):22-33.

PMID: 39968828 PMC: 11905879. DOI: 10.1002/em.70002.

Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids.

Correia de Sousa M, Delangre E, Berthou F, El Harane S, Maeder C, Fournier M JHEP Rep. 2024; 6(9):101126.

PMID: 39263327 PMC: 11388170. DOI: 10.1016/j.jhepr.2024.101126.

MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications.

Gan L, Zheng L, Zou J, Luo P, Chen T, Zou J Front Cell Dev Biol. 2024; 12:1437951.

PMID: 39114567 PMC: 11304453. DOI: 10.3389/fcell.2024.1437951.

Dysregulated microRNAs in type 2 diabetes and breast cancer: Potential associated molecular mechanisms.

Improta-Caria A, Ferrari F, Gomes J, Villalta P, Soci U, Stein R World J Diabetes. 2024; 15(6):1187-1198.

PMID: 38983808 PMC: 11229979. DOI: 10.4239/wjd.v15.i6.1187.

References

Zile M, Mehurg S, Arroyo J, Stroud R, DeSantis S, Spinale F . Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ Cardiovasc Genet. 2011; 4(6):614-9. PMC: 3535326. DOI: 10.1161/CIRCGENETICS.111.959841. View

Kim S, Kim A, Lee H, Son Y, Lee G, Lee J . miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun. 2010; 392(3):323-8. DOI: 10.1016/j.bbrc.2010.01.012. View

Vickers K, Shoucri B, Levin M, Wu H, Pearson D, Osei-Hwedieh D . MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology. 2012; 57(2):533-42. PMC: 3470747. DOI: 10.1002/hep.25846. View

Newman M, Thomson J, Hammond S . Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA. 2008; 14(8):1539-49. PMC: 2491462. DOI: 10.1261/rna.1155108. View

Poy M, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P . miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A. 2009; 106(14):5813-8. PMC: 2656556. DOI: 10.1073/pnas.0810550106. View

Wightman B, Ha I, Ruvkun G . Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993; 75(5):855-62. DOI: 10.1016/0092-8674(93)90530-4. View

Cheung O, Puri P, Eicken C, Contos M, Mirshahi F, Maher J . Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology. 2008; 48(6):1810-20. PMC: 2717729. DOI: 10.1002/hep.22569. View

Ambros V . MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003; 113(6):673-6. DOI: 10.1016/s0092-8674(03)00428-8. View

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

10.

Pullen T, da Silva Xavier G, Kelsey G, Rutter G . miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol. 2011; 31(15):3182-94. PMC: 3147603. DOI: 10.1128/MCB.01433-10. View

11.

Lynn F, Skewes-Cox P, Kosaka Y, McManus M, Harfe B, German M . MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes. 2007; 56(12):2938-45. DOI: 10.2337/db07-0175. View

12.

Tsai W, Hsu S, Hsu C, Lai T, Chen S, Shen R . MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012; 122(8):2884-97. PMC: 3408747. DOI: 10.1172/JCI63455. View

13.

Viswanathan S, Daley G, Gregory R . Selective blockade of microRNA processing by Lin28. Science. 2008; 320(5872):97-100. PMC: 3368499. DOI: 10.1126/science.1154040. View

14.

Iliopoulos D, Drosatos K, Hiyama Y, Goldberg I, Zannis V . MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res. 2010; 51(6):1513-23. PMC: 3035515. DOI: 10.1194/jlr.M004812. View

15.

Grueter C, Van Rooij E, Johnson B, DeLeon S, Sutherland L, Qi X . A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell. 2012; 149(3):671-83. PMC: 3340581. DOI: 10.1016/j.cell.2012.03.029. View

16.

Rayner K, Esau C, Hussain F, McDaniel A, Marshall S, van Gils J . Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature. 2011; 478(7369):404-7. PMC: 3235584. DOI: 10.1038/nature10486. View

17.

Davalos A, Goedeke L, Smibert P, Ramirez C, Warrier N, Andreo U . miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A. 2011; 108(22):9232-7. PMC: 3107310. DOI: 10.1073/pnas.1102281108. View

18.

Cermelli S, Ruggieri A, Marrero J, Ioannou G, Beretta L . Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One. 2011; 6(8):e23937. PMC: 3160337. DOI: 10.1371/journal.pone.0023937. View

19.

Vickers K, Palmisano B, Shoucri B, Shamburek R, Remaley A . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-33. PMC: 3074610. DOI: 10.1038/ncb2210. View

20.

Gatfield D, Le Martelot G, Vejnar C, Gerlach D, Schaad O, Fleury-Olela F . Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 2009; 23(11):1313-26. PMC: 2701584. DOI: 10.1101/gad.1781009. View